RaySearch Laboratories AB ser. B (RAYb)

Currency in SEK
335.00
-1.50(-0.45%)
Closed·
RAYb Scorecard
Full Analysis
Impressive gross profit margins
Earnings results expected in 5 days
Fair Value
Day's Range
330.50341.00
52 wk Range
123.60373.50
Key Statistics
Prev. Close
336.5
Open
338
Day's Range
330.5-341
52 wk Range
123.6-373.5
Volume
91.23K
Average Volume (3m)
119.82K
1-Year Change
154.17%
Book Value / Share
25.41
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RAYb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
335.00
Upside
0.00%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

RaySearch Laboratories AB ser. B Company Profile

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions. It has collaboration with Vision RT for integration of MapRT with RayStation treatment planning system. The company was founded in 2000 and is headquartered in Stockholm, Sweden.

Employees
422
Market
Sweden

Compare RAYb to Peers and Sector

Metrics to compare
RAYb
Peers
Sector
Relationship
P/E Ratio
51.4x23.6x−0.5x
PEG Ratio
0.420.640.00
Price/Book
12.5x2.9x2.6x
Price / LTM Sales
9.1x2.8x3.3x
Upside (Analyst Target)
7.5%16.5%45.4%
Fair Value Upside
Unlock25.9%7.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 335.00

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.52%
Dividend Yield
0.90%
Industry Median 1.55%
Annualised payout
3.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 09, 2025
EPS / Forecast
1.66 / 1.44
Revenue / Forecast
331.70M / 304.00M
EPS Revisions
Last 90 days

RAYb Income Statement

People Also Watch

742.47
AXON
-1.72%
169.40
MILDEF
-1.97%
308.8
NOVOb
-1.81%
162.90
BETSb
-1.93%
202.00
CICN
+4.12%

FAQ

What Stock Exchange Does RaySearch Labs B Trade On?

RaySearch Labs B is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for RaySearch Labs B?

The stock symbol for RaySearch Labs B is "RAYb."

What Is the RaySearch Labs B Market Cap?

As of today, RaySearch Labs B market cap is 11.48B.

What Is RaySearch Labs B's Earnings Per Share (TTM)?

The RaySearch Labs B EPS (TTM) is 6.52.

When Is the Next RaySearch Labs B Earnings Date?

RaySearch Labs B will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is RAYb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has RaySearch Labs B Stock Split?

RaySearch Labs B has split 2 times.

How Many Employees Does RaySearch Labs B Have?

RaySearch Labs B has 422 employees.

What is the current trading status of RaySearch Labs B (RAYb)?

As of 03 Aug 2025, RaySearch Labs B (RAYb) is trading at a price of 335.00, with a previous close of 336.50. The stock has fluctuated within a day range of 330.50 to 341.00, while its 52-week range spans from 123.60 to 373.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.